nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—Erlotinib—pancreatic cancer	0.118	0.361	CbGbCtD
Ceftriaxone—ALB—Irinotecan—pancreatic cancer	0.107	0.326	CbGbCtD
Ceftriaxone—ALB—Fluorouracil—pancreatic cancer	0.103	0.313	CbGbCtD
Ceftriaxone—Anaemia—Gemcitabine—pancreatic cancer	0.00115	0.00171	CcSEcCtD
Ceftriaxone—Phlebitis—Epirubicin—pancreatic cancer	0.00115	0.00171	CcSEcCtD
Ceftriaxone—Leukopenia—Irinotecan—pancreatic cancer	0.00115	0.0017	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Epirubicin—pancreatic cancer	0.00114	0.0017	CcSEcCtD
Ceftriaxone—Paraesthesia—Sunitinib—pancreatic cancer	0.00114	0.00169	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00113	0.00169	CcSEcCtD
Ceftriaxone—Anaemia—Fluorouracil—pancreatic cancer	0.00113	0.00169	CcSEcCtD
Ceftriaxone—Malaise—Gemcitabine—pancreatic cancer	0.00112	0.00167	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00112	0.00167	CcSEcCtD
Ceftriaxone—Dyspepsia—Sunitinib—pancreatic cancer	0.00112	0.00166	CcSEcCtD
Ceftriaxone—Leukopenia—Gemcitabine—pancreatic cancer	0.00112	0.00166	CcSEcCtD
Ceftriaxone—Renal failure—Docetaxel—pancreatic cancer	0.00111	0.00166	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—pancreatic cancer	0.00111	0.00165	CcSEcCtD
Ceftriaxone—Stomatitis—Docetaxel—pancreatic cancer	0.0011	0.00164	CcSEcCtD
Ceftriaxone—Jaundice—Docetaxel—pancreatic cancer	0.0011	0.00164	CcSEcCtD
Ceftriaxone—Leukopenia—Fluorouracil—pancreatic cancer	0.0011	0.00163	CcSEcCtD
Ceftriaxone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00109	0.00162	CcSEcCtD
Ceftriaxone—Pain—Sunitinib—pancreatic cancer	0.00108	0.00161	CcSEcCtD
Ceftriaxone—Discomfort—Irinotecan—pancreatic cancer	0.00108	0.0016	CcSEcCtD
Ceftriaxone—Epistaxis—Docetaxel—pancreatic cancer	0.00107	0.00159	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—pancreatic cancer	0.00106	0.00158	CcSEcCtD
Ceftriaxone—Convulsion—Fluorouracil—pancreatic cancer	0.00106	0.00158	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00106	0.00158	CcSEcCtD
Ceftriaxone—Agranulocytosis—Docetaxel—pancreatic cancer	0.00106	0.00157	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00105	0.00156	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00105	0.00156	CcSEcCtD
Ceftriaxone—Discomfort—Gemcitabine—pancreatic cancer	0.00105	0.00156	CcSEcCtD
Ceftriaxone—Pruritus—Tamoxifen—pancreatic cancer	0.00105	0.00156	CcSEcCtD
Ceftriaxone—Oedema—Irinotecan—pancreatic cancer	0.00104	0.00155	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00104	0.00155	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—pancreatic cancer	0.00104	0.00155	CcSEcCtD
Ceftriaxone—Infection—Irinotecan—pancreatic cancer	0.00104	0.00154	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00104	0.00154	CcSEcCtD
Ceftriaxone—Pruritus—Erlotinib—pancreatic cancer	0.00104	0.00154	CcSEcCtD
Ceftriaxone—Discomfort—Fluorouracil—pancreatic cancer	0.00103	0.00153	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00102	0.00152	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00102	0.00152	CcSEcCtD
Ceftriaxone—Haemoglobin—Docetaxel—pancreatic cancer	0.00102	0.00152	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00102	0.00151	CcSEcCtD
Ceftriaxone—Oedema—Gemcitabine—pancreatic cancer	0.00102	0.00151	CcSEcCtD
Ceftriaxone—Haemorrhage—Docetaxel—pancreatic cancer	0.00102	0.00151	CcSEcCtD
Ceftriaxone—Diarrhoea—Tamoxifen—pancreatic cancer	0.00101	0.00151	CcSEcCtD
Ceftriaxone—Infection—Gemcitabine—pancreatic cancer	0.00101	0.0015	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00101	0.0015	CcSEcCtD
Ceftriaxone—Abdominal pain—Sunitinib—pancreatic cancer	0.001	0.00149	CcSEcCtD
Ceftriaxone—Body temperature increased—Sunitinib—pancreatic cancer	0.001	0.00149	CcSEcCtD
Ceftriaxone—Diarrhoea—Erlotinib—pancreatic cancer	0.001	0.00149	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.001	0.00149	CcSEcCtD
Ceftriaxone—Oedema—Fluorouracil—pancreatic cancer	0.001	0.00149	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000996	0.00148	CcSEcCtD
Ceftriaxone—Infection—Fluorouracil—pancreatic cancer	0.000994	0.00148	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000984	0.00146	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000979	0.00146	CcSEcCtD
Ceftriaxone—Dizziness—Tamoxifen—pancreatic cancer	0.000979	0.00146	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000972	0.00145	CcSEcCtD
Ceftriaxone—Dizziness—Erlotinib—pancreatic cancer	0.000969	0.00144	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—pancreatic cancer	0.000963	0.00143	CcSEcCtD
Ceftriaxone—Erythema multiforme—Docetaxel—pancreatic cancer	0.000961	0.00143	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000947	0.00141	CcSEcCtD
Ceftriaxone—Flushing—Docetaxel—pancreatic cancer	0.000943	0.0014	CcSEcCtD
Ceftriaxone—Vomiting—Tamoxifen—pancreatic cancer	0.000941	0.0014	CcSEcCtD
Ceftriaxone—Paraesthesia—Irinotecan—pancreatic cancer	0.000938	0.0014	CcSEcCtD
Ceftriaxone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000934	0.00139	CcSEcCtD
Ceftriaxone—Rash—Tamoxifen—pancreatic cancer	0.000933	0.00139	CcSEcCtD
Ceftriaxone—Dermatitis—Tamoxifen—pancreatic cancer	0.000933	0.00139	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—pancreatic cancer	0.000932	0.00139	CcSEcCtD
Ceftriaxone—Vomiting—Erlotinib—pancreatic cancer	0.000931	0.00139	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000928	0.00138	CcSEcCtD
Ceftriaxone—Headache—Tamoxifen—pancreatic cancer	0.000927	0.00138	CcSEcCtD
Ceftriaxone—Rash—Erlotinib—pancreatic cancer	0.000924	0.00137	CcSEcCtD
Ceftriaxone—Dermatitis—Erlotinib—pancreatic cancer	0.000923	0.00137	CcSEcCtD
Ceftriaxone—Dyspepsia—Irinotecan—pancreatic cancer	0.000919	0.00137	CcSEcCtD
Ceftriaxone—Headache—Erlotinib—pancreatic cancer	0.000918	0.00137	CcSEcCtD
Ceftriaxone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000914	0.00136	CcSEcCtD
Ceftriaxone—Chills—Docetaxel—pancreatic cancer	0.000912	0.00136	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000905	0.00135	CcSEcCtD
Ceftriaxone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000898	0.00134	CcSEcCtD
Ceftriaxone—Pruritus—Sunitinib—pancreatic cancer	0.000897	0.00133	CcSEcCtD
Ceftriaxone—Pain—Irinotecan—pancreatic cancer	0.000893	0.00133	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000892	0.00133	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000892	0.00133	CcSEcCtD
Ceftriaxone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000881	0.00131	CcSEcCtD
Ceftriaxone—Nausea—Tamoxifen—pancreatic cancer	0.000879	0.00131	CcSEcCtD
Ceftriaxone—Pain—Gemcitabine—pancreatic cancer	0.00087	0.00129	CcSEcCtD
Ceftriaxone—Nausea—Erlotinib—pancreatic cancer	0.00087	0.00129	CcSEcCtD
Ceftriaxone—Diarrhoea—Sunitinib—pancreatic cancer	0.000868	0.00129	CcSEcCtD
Ceftriaxone—Dysgeusia—Docetaxel—pancreatic cancer	0.000866	0.00129	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—pancreatic cancer	0.000862	0.00128	CcSEcCtD
Ceftriaxone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000861	0.00128	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000859	0.00128	CcSEcCtD
Ceftriaxone—Pain—Fluorouracil—pancreatic cancer	0.000855	0.00127	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000854	0.00127	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—pancreatic cancer	0.000848	0.00126	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—pancreatic cancer	0.00084	0.00125	CcSEcCtD
Ceftriaxone—Dizziness—Sunitinib—pancreatic cancer	0.000838	0.00125	CcSEcCtD
Ceftriaxone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000838	0.00125	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000837	0.00125	CcSEcCtD
Ceftriaxone—Abdominal pain—Irinotecan—pancreatic cancer	0.000826	0.00123	CcSEcCtD
Ceftriaxone—Body temperature increased—Irinotecan—pancreatic cancer	0.000826	0.00123	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000826	0.00123	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000826	0.00123	CcSEcCtD
Ceftriaxone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000824	0.00123	CcSEcCtD
Ceftriaxone—Anaemia—Docetaxel—pancreatic cancer	0.000818	0.00122	CcSEcCtD
Ceftriaxone—Vomiting—Sunitinib—pancreatic cancer	0.000806	0.0012	CcSEcCtD
Ceftriaxone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000804	0.0012	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—pancreatic cancer	0.000801	0.00119	CcSEcCtD
Ceftriaxone—Rash—Sunitinib—pancreatic cancer	0.000799	0.00119	CcSEcCtD
Ceftriaxone—Dermatitis—Sunitinib—pancreatic cancer	0.000799	0.00119	CcSEcCtD
Ceftriaxone—Urticaria—Fluorouracil—pancreatic cancer	0.000795	0.00118	CcSEcCtD
Ceftriaxone—Headache—Sunitinib—pancreatic cancer	0.000794	0.00118	CcSEcCtD
Ceftriaxone—Leukopenia—Docetaxel—pancreatic cancer	0.000792	0.00118	CcSEcCtD
Ceftriaxone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000791	0.00118	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—pancreatic cancer	0.000785	0.00117	CcSEcCtD
Ceftriaxone—Palpitations—Docetaxel—pancreatic cancer	0.000782	0.00116	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000777	0.00116	CcSEcCtD
Ceftriaxone—Hypersensitivity—Irinotecan—pancreatic cancer	0.00077	0.00115	CcSEcCtD
Ceftriaxone—Convulsion—Docetaxel—pancreatic cancer	0.000766	0.00114	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000757	0.00113	CcSEcCtD
Ceftriaxone—Nausea—Sunitinib—pancreatic cancer	0.000753	0.00112	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—pancreatic cancer	0.000751	0.00112	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—pancreatic cancer	0.000744	0.00111	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—pancreatic cancer	0.000744	0.00111	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—pancreatic cancer	0.000741	0.0011	CcSEcCtD
Ceftriaxone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000737	0.0011	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—pancreatic cancer	0.000728	0.00108	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000722	0.00107	CcSEcCtD
Ceftriaxone—Oedema—Docetaxel—pancreatic cancer	0.000722	0.00107	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—pancreatic cancer	0.00072	0.00107	CcSEcCtD
Ceftriaxone—Pruritus—Gemcitabine—pancreatic cancer	0.00072	0.00107	CcSEcCtD
Ceftriaxone—Infection—Docetaxel—pancreatic cancer	0.000717	0.00107	CcSEcCtD
Ceftriaxone—Diarrhoea—Irinotecan—pancreatic cancer	0.000715	0.00106	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000713	0.00106	CcSEcCtD
Ceftriaxone—Pruritus—Fluorouracil—pancreatic cancer	0.000708	0.00105	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000707	0.00105	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.0007	0.00104	CcSEcCtD
Ceftriaxone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000696	0.00104	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—pancreatic cancer	0.000695	0.00103	CcSEcCtD
Ceftriaxone—Dizziness—Irinotecan—pancreatic cancer	0.000691	0.00103	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—pancreatic cancer	0.000689	0.00103	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—pancreatic cancer	0.000689	0.00102	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—pancreatic cancer	0.000689	0.00102	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—pancreatic cancer	0.000685	0.00102	CcSEcCtD
Ceftriaxone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000684	0.00102	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—pancreatic cancer	0.000674	0.001	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—pancreatic cancer	0.000666	0.000992	CcSEcCtD
Ceftriaxone—Vomiting—Irinotecan—pancreatic cancer	0.000664	0.000988	CcSEcCtD
Ceftriaxone—Dizziness—Fluorouracil—pancreatic cancer	0.000662	0.000984	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000659	0.000981	CcSEcCtD
Ceftriaxone—Rash—Irinotecan—pancreatic cancer	0.000659	0.00098	CcSEcCtD
Ceftriaxone—Dermatitis—Irinotecan—pancreatic cancer	0.000658	0.000979	CcSEcCtD
Ceftriaxone—Headache—Irinotecan—pancreatic cancer	0.000654	0.000974	CcSEcCtD
Ceftriaxone—Paraesthesia—Docetaxel—pancreatic cancer	0.000648	0.000965	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000648	0.000964	CcSEcCtD
Ceftriaxone—Vomiting—Gemcitabine—pancreatic cancer	0.000647	0.000963	CcSEcCtD
Ceftriaxone—Rash—Gemcitabine—pancreatic cancer	0.000641	0.000955	CcSEcCtD
Ceftriaxone—Dermatitis—Gemcitabine—pancreatic cancer	0.000641	0.000954	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000637	0.000949	CcSEcCtD
Ceftriaxone—Headache—Gemcitabine—pancreatic cancer	0.000637	0.000948	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—pancreatic cancer	0.000636	0.000947	CcSEcCtD
Ceftriaxone—Vomiting—Fluorouracil—pancreatic cancer	0.000636	0.000946	CcSEcCtD
Ceftriaxone—Dyspepsia—Docetaxel—pancreatic cancer	0.000636	0.000946	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000634	0.000944	CcSEcCtD
Ceftriaxone—Rash—Fluorouracil—pancreatic cancer	0.000631	0.000938	CcSEcCtD
Ceftriaxone—Dermatitis—Fluorouracil—pancreatic cancer	0.00063	0.000938	CcSEcCtD
Ceftriaxone—Headache—Fluorouracil—pancreatic cancer	0.000627	0.000932	CcSEcCtD
Ceftriaxone—Nausea—Irinotecan—pancreatic cancer	0.00062	0.000923	CcSEcCtD
Ceftriaxone—Pain—Docetaxel—pancreatic cancer	0.000617	0.000919	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—pancreatic cancer	0.000615	0.000915	CcSEcCtD
Ceftriaxone—Nausea—Gemcitabine—pancreatic cancer	0.000604	0.000899	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.0006	0.000892	CcSEcCtD
Ceftriaxone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000595	0.000885	CcSEcCtD
Ceftriaxone—Nausea—Fluorouracil—pancreatic cancer	0.000594	0.000884	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00059	0.000878	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—pancreatic cancer	0.000589	0.000876	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—pancreatic cancer	0.000588	0.000875	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—pancreatic cancer	0.000584	0.000869	CcSEcCtD
Ceftriaxone—Abdominal pain—Docetaxel—pancreatic cancer	0.000571	0.000849	CcSEcCtD
Ceftriaxone—Body temperature increased—Docetaxel—pancreatic cancer	0.000571	0.000849	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—pancreatic cancer	0.000569	0.000847	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000554	0.000824	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—pancreatic cancer	0.000552	0.000821	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—pancreatic cancer	0.000548	0.000816	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—pancreatic cancer	0.000544	0.00081	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000541	0.000804	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—pancreatic cancer	0.000538	0.000801	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—pancreatic cancer	0.000534	0.000795	CcSEcCtD
Ceftriaxone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000532	0.000792	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—pancreatic cancer	0.000527	0.000785	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—pancreatic cancer	0.000517	0.000769	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000512	0.000762	CcSEcCtD
Ceftriaxone—Pruritus—Docetaxel—pancreatic cancer	0.000511	0.00076	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—pancreatic cancer	0.00051	0.000759	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—pancreatic cancer	0.000507	0.000755	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—pancreatic cancer	0.000502	0.000747	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—pancreatic cancer	0.000498	0.000741	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—pancreatic cancer	0.000494	0.000735	CcSEcCtD
Ceftriaxone—Diarrhoea—Docetaxel—pancreatic cancer	0.000494	0.000735	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—pancreatic cancer	0.000488	0.000726	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—pancreatic cancer	0.000487	0.000725	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000487	0.000725	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—pancreatic cancer	0.000484	0.00072	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—pancreatic cancer	0.000478	0.000712	CcSEcCtD
Ceftriaxone—Dizziness—Docetaxel—pancreatic cancer	0.000477	0.00071	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000477	0.000709	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000471	0.000701	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—pancreatic cancer	0.000464	0.000691	CcSEcCtD
Ceftriaxone—Vomiting—Docetaxel—pancreatic cancer	0.000459	0.000683	CcSEcCtD
Ceftriaxone—Rash—Docetaxel—pancreatic cancer	0.000455	0.000677	CcSEcCtD
Ceftriaxone—Dermatitis—Docetaxel—pancreatic cancer	0.000455	0.000677	CcSEcCtD
Ceftriaxone—Headache—Docetaxel—pancreatic cancer	0.000452	0.000673	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000451	0.00067	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—pancreatic cancer	0.000451	0.00067	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—pancreatic cancer	0.000448	0.000666	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000441	0.000656	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—pancreatic cancer	0.000437	0.000651	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000436	0.000648	CcSEcCtD
Ceftriaxone—Nausea—Docetaxel—pancreatic cancer	0.000429	0.000638	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—pancreatic cancer	0.000429	0.000638	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—pancreatic cancer	0.000416	0.00062	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000405	0.000602	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000401	0.000597	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000398	0.000593	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000397	0.00059	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—pancreatic cancer	0.000387	0.000576	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—pancreatic cancer	0.000385	0.000573	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—pancreatic cancer	0.000385	0.000573	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—pancreatic cancer	0.000385	0.000573	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000371	0.000553	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000368	0.000548	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000359	0.000534	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—pancreatic cancer	0.000358	0.000533	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000356	0.00053	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000356	0.00053	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—pancreatic cancer	0.000345	0.000513	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—pancreatic cancer	0.000333	0.000496	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000332	0.000494	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—pancreatic cancer	0.000322	0.000479	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—pancreatic cancer	0.000319	0.000474	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—pancreatic cancer	0.00031	0.000461	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000308	0.000459	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—pancreatic cancer	0.000307	0.000457	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—pancreatic cancer	0.000307	0.000456	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—pancreatic cancer	0.000305	0.000454	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—pancreatic cancer	0.000298	0.000443	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—pancreatic cancer	0.000289	0.00043	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—pancreatic cancer	0.000287	0.000426	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—pancreatic cancer	0.000284	0.000423	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—pancreatic cancer	0.000284	0.000422	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—pancreatic cancer	0.000282	0.00042	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—pancreatic cancer	0.000268	0.000398	CcSEcCtD
